These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27649015)

  • 1. [Hospital Mortality in Parkinson's Disease: Retrospective Analysis in a Portuguese Tertiary Centre].
    Martins J; Rua A; Vila Chã N
    Acta Med Port; 2016 May; 29(5):315-8. PubMed ID: 27649015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring the burden and mortality of hospitalisation in Parkinson's disease: A cross-sectional analysis of the English Hospital Episodes Statistics database 2009-2013.
    Low V; Ben-Shlomo Y; Coward E; Fletcher S; Walker R; Clarke CE
    Parkinsonism Relat Disord; 2015 May; 21(5):449-54. PubMed ID: 25737205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Frailty Scale predicts inpatient mortality in older hospitalised patients with idiopathic Parkinson's disease.
    Torsney KM; Romero-Ortuno R
    J R Coll Physicians Edinb; 2018 Jun; 48(2):103-107. PubMed ID: 29992197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and causes of death in idiopathic Parkinson's disease: results from the Aberdeen whole population study.
    Ebmeier KP; Calder SA; Crawford JR; Stewart L; Besson JA; Mutch WJ
    Scott Med J; 1990 Dec; 35(6):173-5. PubMed ID: 2077649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality from Parkinson's disease in China: Findings from a five-year follow up study in Shanghai.
    Wang G; Li XJ; Hu YS; Cheng Q; Wang CF; Xiao Q; Liu J; Ma JF; Zhou HY; Pan J; Tan YY; Wang Y; Chen SD
    Can J Neurol Sci; 2015 Jul; 42(4):242-7. PubMed ID: 26153040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence, differential diagnosis, work capacity, mortality and cause of death in Parkinson disease].
    Eichhorn T; Oertel WH
    Versicherungsmedizin; 1994 Aug; 46(4):122-8. PubMed ID: 7941221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Deaths in a Tunisian psychiatric hospital: an eleven-year retrospective study].
    Zgueb Y; Jomli R; Ouertani A; Hechmi S; Ouanes S; Nacef F; Banaser A
    Encephale; 2014 Oct; 40(5):416-22. PubMed ID: 25132014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Welding occupations and mortality from Parkinson's disease and other neurodegenerative diseases among United States men, 1985-1999.
    Stampfer MJ
    J Occup Environ Hyg; 2009 May; 6(5):267-72. PubMed ID: 19204865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.
    Hely MA; Morris JG; Traficante R; Reid WG; O'Sullivan DJ; Williamson PM
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):300-7. PubMed ID: 10449550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality from Parkinson's disease: a population-based prospective study (NEDICES).
    Posada IJ; Benito-León J; Louis ED; Trincado R; Villarejo A; Medrano MJ; Bermejo-Pareja F
    Mov Disord; 2011 Dec; 26(14):2522-9. PubMed ID: 21915906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical spectrum of Parkinson's disease from Pakistan.
    Khealani BA; Baig SM
    Singapore Med J; 2006 Dec; 47(12):1075-9. PubMed ID: 17139405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in Parkinson's disease. Relation with motor and non-motor features.
    de Lau LM; Verbaan D; Marinus J; van Hilten JJ
    Parkinsonism Relat Disord; 2014 Jun; 20(6):613-6. PubMed ID: 24679900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality and quality of death certification in a cohort of patients with Parkinson's disease and matched controls in North Wales, UK at 18 years: a community-based cohort study.
    Hobson P; Meara J
    BMJ Open; 2018 Feb; 8(2):e018969. PubMed ID: 29444783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
    Kashihara K; Ohno M; Katsu Y
    Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.
    Derejko M; Sławek J; Wieczorek D; Brockhuis B; Dubaniewicz M; Lass P
    Nucl Med Commun; 2006 Dec; 27(12):945-51. PubMed ID: 17088679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for early mortality in Parkinson's disease.
    Oosterveld LP; Allen JC; Reinoso G; Seah SH; Tay KY; Au WL; Tan LC
    Parkinsonism Relat Disord; 2015 Mar; 21(3):226-30. PubMed ID: 25572499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and relation of dementia to various factors in Parkinson's disease.
    Rana AQ; Yousuf MS; Naz S; Qa'aty N
    Psychiatry Clin Neurosci; 2012 Feb; 66(1):64-8. PubMed ID: 22250611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.